Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
The Battery ShowThe Battery Show
Not Confirmed
Not Confirmed
06-09 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
The Battery ShowThe Battery Show
Industry Trade Show
Not Confirmed
06-09 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
30 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250930417047/en/Precision-BioSciences-Announces-Late-Breaking-Poster-Presentation-at-the-30th-Annual-International-Congress-of-the-World-Muscle-Society
12 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-12/precision-biosciences-presents-data-from-the-phase-1-eliminate-b-trial-of-pbgene-hbv-at-the-6th-inte
12 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250912033938/en/Precision-BioSciences-Presents-Data-from-the-Phase-1-ELIMINATE-B-Trial-of-PBGENE-HBV-at-the-6th-International-Coalition-to-Eliminate-HBV-Cure-Symposium
08 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-08/precision-biosciences-announces-us-patent-covering-pbgene-hbv-for-chronic-hepatitis-b-and-updates
07 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250807503495/en/Precision-BioSciences-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update
06 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250806619711/en/Precision-BioSciences-Announces-Phase-1-Safety-and-Efficacy-for-Cohort-1-Lowest-Dose-Level-in-ELIMINATE-B-a-First-In-Human-Trial-of-PBGENE-HBV-for-Chronic-Hepatitis-B
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE